CIRCULATING TUMOR CELLS: POTENTIAL MARKERS OF MINIMAL RESIDUAL DISEASE IN OVARIAN CANCER? - A STUDY OF THE OVCAD CONSORTIUM

被引：0
|
作者：
Obermayr, E. [1 ]
Bednarz-Knoll, N. [2 ]
Orsetti, B. [3 ]
Weier, H. U. [4 ]
Lambrechts, S. [5 ]
Castillo-Tong, D. Cacsire [1 ]
Reinthaller, A. [1 ]
Braicu, E. [6 ]
Mahner, S. [7 ]
Sehouli, J. [6 ]
Vergote, I. [5 ]
Theillet, C. [3 ]
Zeillinger, R. [1 ]
Brandt, B. [8 ]
机构：
[1] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria
[2] Univ Medial Ctr Eppendorf, Inst Tumor Biol, Hamburg, Germany
[3] Univ Montpellier, INSERM, U1194, Montpellier, France
[4] Lawrence Berkeley Natl Lab, Life Sci, Berkeley, CA USA
[5] Leuven Canc Inst, Obstet & Gynecol, Leuven, Belgium
[6] Charite Univ Med Berlin, Gynecol, Berlin, Germany
[7] Univ Medial Ctr Eppendorf, Gynecol Gynecol Oncol, Hamburg, Germany
[8] Univ Med Ctr Schleswig Holstein, Clin Chem, Kiel, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0925
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [1] Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
    Obermayr, Eva
    Bednarz-Knoll, Natalia
    Orsetti, Beatrice
    Weier, Heinz-Ulrich
    Lambrechts, Sandrina
    Castillo-Tong, Dan Cacsire
    Reinthaller, Alexander
    Braicu, Elena Ioana
    Mahner, Sven
    Sehouli, Jalid
    Vergote, Ignace
    Theillet, Charles
    Zeillinger, Robert
    Brandt, Burkhard
    ONCOTARGET, 2017, 8 (63) : 106415 - 106428
  • [2] CIRCULATING TUMOR CELLS: POTENTIAL MARKERS OF MINIMAL RESIDUAL DISEASE IN OVARIAN CANCER? - A STUDY OF THE OVCAD CONSORTIUM
    Obermayr, E.
    Bednarz-Knoll, N.
    Orsetti, B.
    Weier, H. U.
    Lambrechts, S.
    Castillo-Tong, D. Cacsire
    Reinthaller, A.
    Braicu, E.
    Mahner, S.
    Sehouli, J.
    Vergote, I.
    Theillet, C.
    Zeillinger, R.
    Brandt, B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1819 - 1819
  • [3] The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium
    Obermayr, Eva
    Reiner, Angelika
    Brandt, Burkhard
    Braicu, Elena Ioana
    Reinthaller, Alexander
    Loverix, Liselore
    Concin, Nicole
    Woelber, Linn
    Mahner, Sven
    Sehouli, Jalid
    Vergote, Ignace
    Zeillinger, Robert
    CANCERS, 2021, 13 (11)
  • [4] Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium
    Obermayr, Eva
    Braicu, Elena Ioana
    Polterauer, Stephan
    Loverix, Liselore
    Concin, Nicole
    Woelber, Linn
    Mahner, Sven
    Sehouli, Jalid
    Van Gorp, Toon
    Vergote, Ignace
    Zeillinger, Robert
    Aust, Stefanie
    CANCERS, 2021, 13 (23)
  • [5] Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium
    Obermayr, Eva
    Castillo-Tong, Dan Cacsire
    Pils, Dietmar
    Speiser, Paul
    Braicu, Ioana
    Van Gorp, Toon
    Mahner, Sven
    Sehouli, Jalid
    Vergote, Ignace
    Zeillinger, Robert
    GYNECOLOGIC ONCOLOGY, 2013, 128 (01) : 15 - 21
  • [6] Minimal residual disease and circulating tumor cells in breast cancer
    Ignatiadis, Michail
    Reinholz, Monica
    BREAST CANCER RESEARCH, 2011, 13 (05)
  • [7] Minimal residual disease and circulating tumor cells in breast cancer
    Michail Ignatiadis
    Monica Reinholz
    Breast Cancer Research, 13
  • [8] Characterization of Circulating Tumor Cells for Early Detection of Minimal Residual Disease in Colorectal Cancer: A Pilot Study
    Prisant, Nadia
    Avivi, Camila
    Siloni, Goni Hout
    Pavlova, Vera
    Barak, Yoash
    Rozenberg, Maayan
    Franchi, Gian Martino
    Carbone, Roberta
    Katz, Ruth L.
    Barshack, Iris
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S47 - S47
  • [9] Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium
    Pils, Dietmar
    Hager, Gudrun
    Tong, Dan
    Aust, Stefanie
    Heinze, Georg
    Kohl, Maria
    Schuster, Eva
    Wolf, Andrea
    Sehouli, Jalid
    Braicu, Ioana
    Vergote, Ignace
    Cadron, Isabelle
    Mahner, Sven
    Hofstetter, Gerda
    Speiser, Paul
    Zeillinger, Robert
    CANCER SCIENCE, 2012, 103 (07) : 1334 - 1341
  • [10] Circulating Tumor DNA as a Marker of Minimal Residual Disease in Colorectal Cancer
    Kopetz, Scott
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (12) : 791 - 793
12345